These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 27932377)
1. Pfizer is fined £84m for "exploiting opportunity" to hike price of phenytoin. Hawkes N BMJ; 2016 Dec; 355():i6628. PubMed ID: 27932377 [No Abstract] [Full Text] [Related]
2. Pfizer could face large fine over pricing of generic phenytoin. Hawkes N BMJ; 2016 Nov; 355():i6401. PubMed ID: 27895057 [No Abstract] [Full Text] [Related]
3. States sue generic drug makers for alleged price fixing. McCarthy M BMJ; 2016 Dec; 355():i6764. PubMed ID: 27993771 [No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921 [No Abstract] [Full Text] [Related]
5. Cost of fosphenytoin. Marble EL Ann Emerg Med; 1998 Jan; 31(1):138-9. PubMed ID: 9437362 [No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief. Health Policy Tracking Service, A Service of Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837 [No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: cost savings. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891 [No Abstract] [Full Text] [Related]
8. Lower phenytoin serum levels in persons switched from brand to generic phenytoin. Perron R Neurology; 2005 Apr; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15858865 [No Abstract] [Full Text] [Related]
9. Nine drug company chiefs are charged with conspiracy to defraud NHS. Dyer O BMJ; 2006 Apr; 332(7546):872. PubMed ID: 16613948 [No Abstract] [Full Text] [Related]
10. Dormant Commerce Clause--Extraterritoriality Doctrine--Fourth Circuit Invalidates Maryland Statute Regulating Price Gouging in the Sale Of Generic Drugs.--Association for Accessible Medicines v. Frosh, 887 F.3d 664 (4th Cir. 2018). Harv Law Rev; 2019 Apr; 132(6):1748-55. PubMed ID: 30995706 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396 [No Abstract] [Full Text] [Related]
12. Generic drug firm settles claim that it was paid to stay out of market. Dyer O BMJ; 2015 Apr; 350():h2282. PubMed ID: 25920419 [No Abstract] [Full Text] [Related]
13. Teva Pharmaceuticals v. Sandoz: availability of generic glatiramer acetate and the impact to patent litigation claim construction. Fogel LE; Ray CJ Expert Opin Ther Pat; 2015 Jan; 25(1):1-4. PubMed ID: 25363310 [TBL] [Abstract][Full Text] [Related]
14. The impact of price-cap regulations on market entry by generic pharmaceutical firms. Zhang W; Sun H; Guh D; Anis AH Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):231-238. PubMed ID: 27936981 [TBL] [Abstract][Full Text] [Related]
15. Brazil and USA at loggerheads over production of generic antiretrovirals. Ahmad K Lancet; 2001 Feb; 357(9254):453. PubMed ID: 11273079 [No Abstract] [Full Text] [Related]
16. Price regulation and generic competition in the pharmaceutical market. Dalen DM; Strøm S; Haabeth T Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230 [TBL] [Abstract][Full Text] [Related]